Future of Stock Markets: Raising Capital Through ICO

‘We Have A Purpose’: Miami Uniform Business Cranks Out Protective Face Masks

Blockvest Says Issues Of Fact In ICO Fraud Case Remain

ICO Uniforms commits to making CDC recommended masks

Miami tailors shift to mask-making as experts call for increased protection

ICO received 129,354 complaints about nuisance calls and texts in 2019

How the UK is loosening its data rules to tackle coronavirus

UK’s ICO Says Mobile Tracking is Legal During COVID-19 Crisis

Coronavirus-tracking smartphone apps get green light from data watchdog

ICO approves use of British mobile phone tracking data to fight spread of coronavirus

ICO approves use of anonymised mobile data to track Covid-19 spread

Ico and Shadow of the Colossus Creators Signs Deal with Epic Games

SEC Seeks Early Judgement in Lawsuit Over Kik’s $100M ICO

SEC wins injunction against Telegram blockchain launch in key ICO case

Jervois Finalises ICO BFS; Reviews Plans in Response to Covid-19

Plaintiffs in Tezos ICO Class Action Reach Ground-Breaking $25M Settlement Deal

Atari Is Not Releasing an ICO Token… It’s Releasing 2 Tokens and a Crypto Casino

ICO Vows “Reasonable and Pragmatic” Flexibility on Data Protection, During Outbreak

SEC Wins Preliminary Injunction In Telegram $1.7B ICO Case

How Cryptocurrencies are Evolving Past the Traditional ICO

Tezos will reach settlements soon as lawsuits become a burden

SNP Government cleared of leaking personal data over Alex Salmond misconduct probe

SEC Fines Russian Firm for Failing to Disclose Paid-For ICO Reviews

iCo Therapeutics Inc. Announces Closing of $2.1 milion private Placement Financing

iCo Therapeutics Inc. Announces Closing of $2.1 Million Private Placement Financing

This ICO Startup Didn’t Die During Crypto Winter. It Has DAI to Thank

US Financial Regulators Reach $7M Settlement Over PlexCorps ICO

Crypto Startups Still Raising Millions in Capital Despite ICO Decline

Kik ICO Trial: Lawyers Issue 130-Page Response Claiming SEC ‘Twisted Facts’

iCo Therapeutics Provides Corporate Update